Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,132 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200B 1765 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S SequentialCompany profile Develops non-invasive multi-omic testing platform for skin health and cosmetics using AI and microbiome analysis Develops non-invasive multi-omic testing platform for skin health and cosmetics using AI and microbiome analysis | $3.5M | Seed | Healthtech | United States | Investors | |
| D DefinityCompany profile Provides a vendor-neutral healthcare workforce platform for hospitals and health systems Provides a vendor-neutral healthcare workforce platform for hospitals and health systems | $7M | Series A | Healthtech | United States | Investors | |
| ST Surf TherapeuticsCompany profile Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases | $6M | Seed | Healthtech | United States | Investors | |
| L LaminarCompany profile Open-source observability platform for tracing and debugging long-running AI agents Open-source observability platform for tracing and debugging long-running AI agents | $3M | Seed | AI | United States | Investors | |
| C Provides in-app communication platform with conversational AI agents | $6.5M | StrategicUndisclosed | Enterprise software | United States | Investors | |
| T Builds ops agents for US manufacturers to automate operational work | $7M | Seed | Industrial tech | United States | Investors | |
| IC Imperative CareCompany profile Develops treatments for patients suffering from thromboembolic disease Develops treatments for patients suffering from thromboembolic disease | $100M | Growth | Healthtech | United States | Investors | |
| B Builds Managed ABM Operating System for enterprise B2B revenue teams | $6.6M | Seed | Enterprise software | United States | Investors | |
| E EileenCompany profile AI-powered retail execution platform helping CPG and Bev Alc brands track in-store shelf performance AI-powered retail execution platform helping CPG and Bev Alc brands track in-store shelf performance | $1M | Pre-SeedPre-seed | Ecommerce | United States | Investors | |
| IG Develops infrastructure for tokenized securities | $21M | Series A | Fintech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.